Previous Close
$30.7
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$4.5 billion USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn)....
Community
- 0 posts discussing
0
Watchers
0
Visitors